Publication:
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries

dc.contributor.authorKresken, M.
dc.contributor.authorKoerber-Irrgang, B.
dc.contributor.authorBiedenbach, D. J.
dc.contributor.authorBatista, N.
dc.contributor.authorBesard, V.
dc.contributor.authorCanton, R.
dc.contributor.authorGarcia-Castillo, M.
dc.contributor.authorKalka-Moll, W.
dc.contributor.authorPascual, A.
dc.contributor.authorSchwarz, R.
dc.contributor.authorVan Meensel, B.
dc.contributor.authorWisplinghoff, H.
dc.contributor.authorSeifert, H.
dc.contributor.authoraffiliation[Kresken, M.] Antiinfect Intelligence GmbH, D-53359 Rheinbach, Germany
dc.contributor.authoraffiliation[Koerber-Irrgang, B.] Antiinfect Intelligence GmbH, D-53359 Rheinbach, Germany
dc.contributor.authoraffiliation[Biedenbach, D. J.] Int Hlth Management Associates Inc, Schaumburg, IL USA
dc.contributor.authoraffiliation[Batista, N.] Hosp Univ Virgen Macarena, Microbiol Serv, Seville, Spain
dc.contributor.authoraffiliation[Pascual, A.] Hosp Univ Virgen Macarena, Microbiol Serv, Seville, Spain
dc.contributor.authoraffiliation[Besard, V.] Practimed CVBA Clin Lab, Tessenderlo, Belgium
dc.contributor.authoraffiliation[Canton, R.] Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Castillo, M.] Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain
dc.contributor.authoraffiliation[Canton, R.] Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Castillo, M.] Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain
dc.contributor.authoraffiliation[Kalka-Moll, W.] Med Versorgungszentrum Dr Stein & Kollegen, Monchengladbach, Germany
dc.contributor.authoraffiliation[Schwarz, R.] Med Versorgungszentrum Dr Stein & Kollegen, Monchengladbach, Germany
dc.contributor.authoraffiliation[Van Meensel, B.] MCH Leuven, Leuven, Belgium
dc.contributor.authoraffiliation[Wisplinghoff, H.] Lab Med Koln Dres Med Wisplinghoff & Kollegen, Cologne, Germany
dc.contributor.authoraffiliation[Seifert, H.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany
dc.contributor.authoraffiliation[Seifert, H.] German Ctr Infect Res, Bonn, Germany
dc.contributor.funderMerck Inc.
dc.date.accessioned2023-02-12T02:20:44Z
dc.date.available2023-02-12T02:20:44Z
dc.date.issued2016-01-01
dc.description.abstractEnterobacteriaceae causing community-acquired urinary tract infections were examined in selected outpatient clinics and hospitals in Belgium, Germany and Spain using EUCAST breakpoints for susceptibility. A total of 1190 isolates were collected. Escherichia coli isolates were resistant to amoxicillin-clavulanic acid (28.1%), ciprofloxacin (23.4%) and trimethoprim-sulfamethoxazole (21.4%) compared with fosfomycin and nitrofurantoin (each,
dc.identifier.doi10.1016/j.cmi.2015.08.019
dc.identifier.essn1469-0691
dc.identifier.issn1198-743X
dc.identifier.unpaywallURLhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X15008058/pdf
dc.identifier.urihttp://hdl.handle.net/10668/18745
dc.identifier.wosID368024800017
dc.issue.number1
dc.journal.titleClinical microbiology and infection
dc.journal.titleabbreviationClin. microbiol. infect.
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.publisherElsevier sci ltd
dc.rights.accessRightsopen access
dc.subjectAge
dc.subjectcephalosporin
dc.subjectextended-spectrum beta-lactamase rates
dc.subjectgender
dc.subjectresistance
dc.subjectEscherichia-coli
dc.subjectBeta-lactamases
dc.subjectResistance
dc.subjectSusceptibility
dc.subjectTrimethoprim
dc.subjectAntibiotics
dc.subjectPathogens
dc.subjectEvolution
dc.subjectTherapy
dc.titleComparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number22
dc.wostypeArticle
dspace.entity.typePublication

Files